Literature DB >> 1371018

Treatment of myelodysplastic syndromes with hemopoietic growth factors.

P L Greenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1371018

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

Review 1.  Colony-stimulating factors. Present status and future potential.

Authors:  R M Fox
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

2.  Treatment of myelodysplastic syndrome with low-dose human granulocyte colony-stimulating factor: a multicenter study.

Authors:  S Chuncharunee; T Intragumtornchai; B Chaimongkol; W Prayoonwiwat; A Leelasiri; A Lekhakula; K Chansung; Y Yoshida
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

Review 3.  Recent-onset myelodysplastic syndrome mimicking acute leukemia during infection.

Authors:  H D Friedman; S A Landaw
Journal:  Ann Hematol       Date:  1996-02       Impact factor: 3.673
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.